Gut Microbe Redux

The theory that people can largely be divided into three groups based on their dominant gut microbiota species is called into question.

Written byHannah Waters
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Bacteroides fragilis, a common gut bacterium.WIKIMEDIA COMMONS, CENTERS FOR DISEASE CONTROL AND PREVENTION

Last year, research suggested that, while everyone has gut bacteria, people can be divided into three groups based on their predominant species: Bacteroides, Prevotella, or Ruminococcus. Clinicians hope to use a person’s enterotype—or gut bacteria grouping—to better understand obesity and gastrointestinal disease, and perhaps to develop treatments.

But those groups may not be so well defined, according to scientists presenting at the International Human Microbiome Congress in Paris, reported Nature.

One researcher replicated the analysis in 663 people and, while his enterotypes were similar to the original research, some people had more than one defining bacterial species and, occasionally, groups overlapped.

Meanwhile, another team replicated the study in more than 1,200 adults and found more of a continuum of gut microbiota than any individual groups.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies